Phase I/II trial assessing bendamustine plus bortezomib combination therapy for the treatment of patients with relapsed or refractory multiple myeloma
Berenson, James R., Yellin, Ori, Bessudo, Alberto, Boccia, Ralph V., Noga, Stephen J., Gravenor, Donald S., Patel-Donnelly, Dipti, Siegel, Robert S., Kewalramani, Tarun, Gorak, Edward J., Nassir, YourVolume:
160
Language:
english
Journal:
British Journal of Haematology
DOI:
10.1111/bjh.12129
Date:
February, 2013
File:
PDF, 304 KB
english, 2013